Literature DB >> 1861548

Prospective evaluation of vertical banded gastroplasty as the primary operation for morbid obesity.

M L Nightengale1, M G Sarr, K A Kelly, M D Jensen, A R Zinsmeister, P J Palumbo.   

Abstract

Our previous experience with vertical (nonbanded) gastroplasty proved disappointing because of unsatisfactory maintenance of weight loss. Vertical banded gastroplasty seemed to be an attractive alternative operation because it provided an externally reinforced (banded) stoma that would not enlarge over time. In this study, our aim was to determine prospectively the results of vertical banded gastroplasty used as a primary, weight-reducing procedure in patients with morbid obesity. Seventy consecutive patients with morbid obesity (mean weight, 139 kg), all of whom had obesity-related complications, underwent vertical banded gastroplasty and prospective follow-up. The hospital mortality was nil, and substantial morbidity occurred in 3% (two patients). Long-term achievement and maintenance of satisfactory weight loss, however, were variable. The median weight loss at 1 year after operation was 36.7 kg or 48% of excess body weight. At 3 years postoperatively, however, weight loss was only 32.4 kg or 40% of excess body weight, and only 38% of patients had achieved and maintained a weight loss of 50% or more of their preoperative excess body weight. Vertical banded gastroplasty caused major changes in eating habits, and many patients were unable to eat red meat or untoasted bread; moreover, approximately 30 to 50% of patients continued to vomit once or more per week. Despite theoretically attractive advantages as a weight-reduction operation, vertical banded gastroplasty does not seem to be the optimal procedure for most patients with morbid obesity.

Entities:  

Mesh:

Year:  1991        PMID: 1861548     DOI: 10.1016/s0025-6196(12)61194-x

Source DB:  PubMed          Journal:  Mayo Clin Proc        ISSN: 0025-6196            Impact factor:   7.616


  18 in total

1.  Gastroesophageal reflux after intact vertical banded gastroplasty: correction by conversion to Roux-en-Y gastric bypass.

Authors:  B M Balsiger; M M Murr; J Mai; M G Sarr
Journal:  J Gastrointest Surg       Date:  2000 May-Jun       Impact factor: 3.452

Review 2.  Obesity surgery: pros and cons.

Authors:  J A Waitman; L J Aronne
Journal:  J Endocrinol Invest       Date:  2002-11       Impact factor: 4.256

Review 3.  Changes in neurohormonal gut peptides following bariatric surgery.

Authors:  C N Ochner; C Gibson; M Shanik; V Goel; A Geliebter
Journal:  Int J Obes (Lond)       Date:  2010-07-13       Impact factor: 5.095

4.  Ten and more years after vertical banded gastroplasty as primary operation for morbid obesity.

Authors:  B M Balsiger; J L Poggio; J Mai; K A Kelly; M G Sarr
Journal:  J Gastrointest Surg       Date:  2000 Nov-Dec       Impact factor: 3.452

5.  [Surgical therapy of extreme obesity].

Authors:  B Husemann
Journal:  Langenbecks Arch Chir       Date:  1995

Review 6.  Laparoscopic conversion of vertical banded gastroplasty to a Roux-en-Y gastric bypass.

Authors:  S Ikramuddin; T A Kellogg; D B Leslie
Journal:  Surg Endosc       Date:  2007-09-04       Impact factor: 4.584

7.  Prospective evaluation and 7-year follow-up of Swedish adjustable gastric banding in adults with extreme obesity.

Authors:  Bruno M Balsiger; Daniel Ernst; Daniel Giachino; Ruedi Bachmann; Andreas Glaettli
Journal:  J Gastrointest Surg       Date:  2007-09-01       Impact factor: 3.452

8.  Long-term results of bariatric restrictive procedures: a prospective study.

Authors:  Ruben Schouten; Dorothee C Wiryasaputra; Francois M H van Dielen; Wim G van Gemert; Jan Willem M Greve
Journal:  Obes Surg       Date:  2010-12       Impact factor: 4.129

9.  Reoperative bariatric surgery. Lessons learned to improve patient selection and results.

Authors:  K E Behrns; C D Smith; K A Kelly; M G Sarr
Journal:  Ann Surg       Date:  1993-11       Impact factor: 12.969

10.  Indications and results of reversal of vertical banded gastroplasty (VBG).

Authors:  Rebecca Thoreson; Joseph J Cullen
Journal:  J Gastrointest Surg       Date:  2008-09-03       Impact factor: 3.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.